Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab Plus Medium vs High Dose Steroids in Behçet's Uveitis
NCT05105347Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Nov 2021
- Primary completion
- Dec 2026
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of adalimumab in Behçet's disease (BD), sponsored by Peking Union Medical College Hospital. Planned start Nov 2021; status: not yet recruiting.
02
Drugs
03
Conditions
Behçet's disease (BD)
Beyond the preview
Go deeper on NCT05105347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05105347.